IDO1 (indoleamine 2,3 dioxygenase 1) promotes the immunosuppressive tumor microenvironment through multiple mechanisms, including activation of MDSCs (myeloid-derived suppressor cells), Tregs (regulatory T cells), and M2 tumor-associated macrophages, while decreasing recruitment of NK (natural killer) cells and cytotoxic CD8+ T cells. Here, IDO1 is linked to neoplasm.